https://www.ascelia.com/privacy-policy/2023-10-20T13:03:53+02:00https://www.ascelia.com/2025-11-17T06:28:32+01:00https://www.ascelia.com/ir-media/press-releases-news/2019-05-22T16:02:29+02:00https://www.ascelia.com/about-us/2024-10-16T10:48:15+02:00https://www.ascelia.com/therapeutic-areas/2023-04-13T16:20:29+02:00https://www.ascelia.com/pipeline/2023-04-13T16:21:43+02:00https://www.ascelia.com/ir-media/2024-04-04T15:47:32+02:00https://www.ascelia.com/corporate-governance/2024-04-04T16:23:40+02:00https://www.ascelia.com/contact/2026-01-16T12:53:13+01:00https://www.ascelia.com/ir-media/share-shareholders/2022-10-26T12:08:47+02:00https://www.ascelia.com/ir-media/subscribe-to-press-releases/2022-10-26T11:55:05+02:00https://www.ascelia.com/about-us/management/2026-03-23T16:42:38+01:00https://www.ascelia.com/therapeutic-areas/liver-metastases/2024-11-06T13:11:52+01:00https://www.ascelia.com/therapeutic-areas/gastric-cancer/2024-11-06T13:06:00+01:00https://www.ascelia.com/pipeline/orviglance/2024-10-15T10:54:33+02:00https://www.ascelia.com/pipeline/clinical-development-mangoral/2020-05-08T13:59:45+02:00https://www.ascelia.com/pipeline/oncoral/2025-01-07T15:23:36+01:00https://www.ascelia.com/pipeline/clinical-development-oncoral/2021-01-12T12:38:08+01:00https://www.ascelia.com/corporate-governance/agm-2018/2019-02-04T09:52:36+01:00https://www.ascelia.com/corporate-governance/audit-committee/2025-09-15T11:36:42+02:00https://www.ascelia.com/corporate-governance/auditors/2026-05-05T12:08:16+02:00https://www.ascelia.com/corporate-governance/board-of-directors/2024-11-28T11:05:49+01:00https://www.ascelia.com/corporate-governance/general-meeting/2026-04-17T11:05:22+02:00https://www.ascelia.com/corporate-governance/internal-control/2021-02-02T13:23:38+01:00https://www.ascelia.com/corporate-governance/nomination-committee/2026-05-05T12:12:27+02:00https://www.ascelia.com/corporate-governance/nomination-committee-2018/2019-01-15T14:53:54+01:00https://www.ascelia.com/corporate-governance/remuneration-committee/2025-09-15T11:37:59+02:00https://www.ascelia.com/ir-media/subscribe-to-press-releases/subscribe-fail/2018-12-05T14:24:02+01:00https://www.ascelia.com/ir-media/subscribe-to-press-releases/subscribe-success/2022-10-26T11:37:27+02:00https://www.ascelia.com/about-us/board-of-directors/2026-03-23T16:44:41+01:00https://www.ascelia.com/corporate-governance/remuneration/2026-05-05T12:07:22+02:00https://www.ascelia.com/ipo/2021-01-13T13:08:57+01:00https://www.ascelia.com/ir-media/ir-contact/2021-02-01T16:46:29+01:00https://www.ascelia.com/corporate-governance/articles-of-association/2024-10-07T12:36:17+02:00https://www.ascelia.com/financial-calendar/2022-10-26T12:06:16+02:00https://www.ascelia.com/about-cookies/2021-01-21T15:07:06+01:00https://www.ascelia.com/share/2025-04-01T15:15:54+02:00https://www.ascelia.com/ascelia-in-media/2021-10-12T09:35:54+02:00https://www.ascelia.com/equity-research/2025-12-01T13:44:34+01:00https://www.ascelia.com/ir-media/regulatory/2019-05-22T16:01:14+02:00https://www.ascelia.com/rsna2019/2019-10-15T10:51:02+02:00https://www.ascelia.com/ir-media/financial-reports/2021-11-24T15:58:26+01:00https://www.ascelia.com/commercialization-committee/2025-09-15T11:41:34+02:00https://www.ascelia.com/capital-markets-day-2020/2021-10-14T15:22:10+02:00https://www.ascelia.com/capital-markets-day-2020/carl-bjartmar-chief-medical-officer/2021-11-23T10:49:52+01:00https://www.ascelia.com/capital-markets-day-2020/magnus-corfitzen-ceo/2021-11-23T10:48:42+01:00https://www.ascelia.com/capital-markets-day-2020/julie-waras-brogren-chief-commercial-officer/2021-11-23T10:46:56+01:00https://www.ascelia.com/capital-markets-day-2020/expert-point-of-view-us-commercialization/2020-10-21T08:29:39+02:00https://www.ascelia.com/oncoral-phase-2-plans/2021-01-11T14:04:40+01:00https://www.ascelia.com/oncoral-phase-2-plans/magnus-corfitzen-ceo-on-oncoral-phase-2-plans/2021-01-08T08:46:58+01:00https://www.ascelia.com/oncoral-phase-2-plans/carl-bjartmar-chief-medical-officer-on-oncoral-phase-2-plans/2021-01-08T08:46:51+01:00https://www.ascelia.com/oncoral-phase-2-plans/jeff-evans-oncologist-on-oncoral-phase-2-plans/2021-01-08T08:46:45+01:00https://www.ascelia.com/career/andreas-norlin-project-director-head-of-preclinical-development/2022-10-21T13:49:39+02:00https://www.ascelia.com/career/carin-linde-head-of-pharmaceutical-development-manufacturing/2022-01-26T13:22:54+01:00https://www.ascelia.com/career/huanhuan-zhang-financial-controller/2022-01-14T08:58:40+01:00https://www.ascelia.com/career/jeanette-nilsson-clinical-operations-manager/2020-12-08T13:46:47+01:00https://www.ascelia.com/career/meet-us/2023-04-11T11:49:15+02:00https://www.ascelia.com/career/open-positions/2023-03-07T09:23:24+01:00https://www.ascelia.com/career/our-values/2022-10-06T15:49:53+02:00https://www.ascelia.com/career/2023-09-27T14:05:16+02:00https://www.ascelia.com/partnering/2024-05-20T11:15:52+02:00https://www.ascelia.com/prospekt-2/2021-04-15T17:02:13+02:00https://www.ascelia.com/career/maria-luisa-verteramo/2022-04-22T14:22:50+02:00https://www.ascelia.com/career/martin-husebo-businessdevelopmentdirector/2023-02-07T15:24:01+01:00https://www.ascelia.com/ir-media/insiders/2023-11-17T15:21:20+01:00https://www.ascelia.com/rights-issue-2024/2024-08-16T12:43:04+02:00https://www.ascelia.com/rights-issue-2024-2/2024-08-29T10:03:04+02:00https://www.ascelia.com/important-information/2025-04-02T08:28:08+02:00https://www.ascelia.com/warrant-series-to-1/2025-04-01T12:34:23+02:00